G-CSF primed bone marrow in HLA-haploidentical transplantation using post-transplantation cyclophosphamide (PTCY) could promote tolerance and further reduce risk of GVHD

被引：0
|
作者：
Durakovic, Nadira [1 ,2 ]
Peric, Zinaida [1 ,2 ]
Desnica, Lana [2 ]
Serventi-Seiwerth, Ranka [2 ]
Mikulic, Mirta [2 ]
Melamed, Brian [3 ]
Ostojic, Alen [2 ]
Pulanic, Drazen [1 ,2 ]
Roncevic, Pavle [2 ]
Grubic, Zorana [2 ]
Vrhovac, Radovan [1 ,2 ]
机构：
[1] Univ Zagreb, Zagreb, Croatia
[2] UHC Zagreb, Zagreb, Croatia
[3] Gen Hosp Bjelovar, Bjelovar, Croatia
来源：
BONE MARROW TRANSPLANTATION | 2019年 / 54卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P673
引用
收藏
页码：571 / 572
页数：2
相关论文
共 50 条
  • [21] HLA-Haploidentical Stem Cell Transplantation for Malignant Hematological Diseases Using G-CSF Mobilized Bone Marrow and Peripheral Blood Stem Cells
    Luo, Yi
    Tan, Yamin
    Lai, Xiaoyu
    Shi, Jimin
    Zheng, Weiyan
    Huang, He
    [J]. BLOOD, 2010, 116 (21) : 988 - 988
  • [22] Risk factors of HLA-haploidentical transplantation using the combination of unmodified marrow and CD6-depleted G-CSF mobilized blood cells
    Kolb, HJ
    Bigalke, I
    Tischer, J
    Hill, W
    Falk, C
    Simoes, B
    Schmid, C
    Ledderose, G
    [J]. BLOOD, 2005, 106 (11) : 815A - 816A
  • [23] T-cell-replete HLA-haploidentical transplantation using post-transplantation high-dose cyclophosphamide post-transplantation in high-risk and advanced ALL: Feasibilty and early outcome
    Zoellner, A. -K.
    Fritsch, S.
    Prevalsek, D.
    Koehnke, T.
    Hubmann, M.
    Lippl, S.
    Kruger, S.
    Hellmuth, J.
    Mumm, F.
    Barlow, S.
    Ledderose, G.
    Subklewe, M.
    Spiekermann, K.
    Hiddemann, W.
    Albert, M.
    Schmid, C.
    Hausmann, A.
    Tischer, J.
    [J]. Oncology Research and Treatment, 2015, 38 : 35 - 35
  • [24] Post-transplantation cyclophosphamide (Cy) as a single agent for GVHD prophylaxis after HLA matched related and unrelated bone marrow transplantation
    Luznik, L
    Chen, A
    Fuchs, EJ
    Phelps, M
    Crawford, A
    Brodsky, RA
    Huff, CA
    Jones, RJ
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 26 - 26
  • [25] KIR genotype profiling FCγR3A gene polymorphisms in non T-cell depleted, G-CSF primed, HLA-haploidentical bone marrow transplantation
    Canossi, A.
    Aureli, A.
    Del Beato, T.
    Papola, F.
    Santarone, S.
    Coppola, A.
    Arriga, R.
    Arcese, W.
    Di Bartolomeo, P.
    Sconocchia, G.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S145 - S145
  • [26] IMPACT OF HLA DISPARITY ON OUTCOME IN HLA-HAPLOIDENTICAL BONE MARROW TRANSPLANTATION FOLLOWED BY HIGH DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE
    Giannoni, L.
    Raiola, A. M.
    Sacchi, N.
    Garbarino, L.
    Dominietto, A.
    Varaldo, R.
    Bregante, S.
    Di Grazia, C.
    Aquino, S.
    Ibatici, A.
    Gualandi, F.
    Van Lint, M. T.
    Lamparelli, T.
    Risitano, A.
    Bacigalupo, A.
    Angelucci, E.
    [J]. HAEMATOLOGICA, 2017, 102 : 325 - 326
  • [27] Improving Selection for Bone Marrow Donors with a Predictive Collection Score in HLA-Haploidentical Transplantation with Post-Infusion Cyclophosphamide
    Vai, A.
    Bramanti, S.
    Crocchiolo, R.
    Sarina, B.
    Morabito, L.
    Giordano, L.
    Timofeeva, I.
    Capizzuto, R.
    Santoro, A.
    Castagna, L.
    [J]. BONE MARROW TRANSPLANTATION, 2015, 50 : S149 - S150
  • [28] Haploidentical unmanipulated bone marrow transplantation and post-transplantation cyclophosphamide for patient with high risk of acute non-lymphoid leukaemia
    Messina, G.
    Console, G.
    Moscato, T.
    Fedele, R.
    Martino, M.
    Russo, L.
    Cuzzola, M.
    Pontari, A.
    Callea, I.
    Spiniello, E.
    Irrera, G.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S527 - S527
  • [29] Successful engraftment and low incidence of GVHD after haploidentical marrow transplantation using G-CSF primed donor marrow grafts and sequential inimunosuppressants to recipients.
    Ji, SQ
    Xun, CQ
    Chen, HR
    Wang, HX
    [J]. BLOOD, 2001, 98 (11) : 384B - 384B
  • [30] Molecular chimerism and patient outcome in haploidentical, G-CSF primed, unmanipulated bone marrow transplantation for haematological malignant diseases
    Rapanotti, M. C.
    De Angelis, G.
    Viguria, T. M. Suarez
    Luciani, V.
    Panetta, P.
    D'Agostini, F.
    De Felice, L.
    Cerretti, R.
    Cudillo, L.
    Picardi, A.
    Vaccarini, S.
    Mariotti, B.
    Lo Coco, F.
    Arcese, W.
    [J]. BONE MARROW TRANSPLANTATION, 2013, 48 : S242 - S243
12345